The scale stalling isn't a sign the medication stopped working
Clinical trials have shown Semaglutide GLP-1 to help patients lose an average of 15% of their body weight, and liraglutide has demonstrated significant reductions in body weight, body mass index (BMI), and waist circumference
With life-threatening conditions like obesity, diabetes, high blood pressure, and back pain being safely managed, employers have a golden opportunity to reinforce weight loss treatment with solid wellness support, creating a winning combination for both the bottom line and employee wellbeing
Not every patient achieves the weight loss targets they are hoping for, and a meaningful proportion of patients even on maximum doses do not reach the 1520% body weight reduction that clinical guidelines increasingly use as a benchmark for meaningful metabolic benefit
Sensitive or reactive skin types
Then after about seven months on Tirzepatide in my case I gained 1.5 inches in length